Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-136,166
Closed -$1.97M 457
2024
Q2
$1.97M Buy
136,166
+12,044
+10% +$165K 0.01% 321
2024
Q1
$2.06M Sell
124,122
-7,325
-6% -$117K 0.01% 342
2023
Q4
$2.11M Buy
131,447
+10,813
+9% +$144K 0.01% 327
2023
Q3
$1.62M Buy
120,634
+33,591
+39% +$473K 0.01% 337
2023
Q2
$1.5M Hold
87,043
0.01% 357
2023
Q1
$1.44M Sell
87,043
-20,667
-19% -$331K 0.01% 367
2022
Q4
$1.8M Hold
107,710
0.01% 349
2022
Q3
$1.84M Hold
107,710
0.01% 346
2022
Q2
$1.18M Buy
+107,710
New +$1.28M 0.01% 365

Other funds holding HLVX

Fred Alger Management's HLVX Position: Q3 2024 in Review

Fred Alger Management sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 136,166 shares — an estimated $1.97M sold.

Fred Alger Management first reported a position in HLVX in Q2 2022 and held it in 9 quarters. The position peaked at $2.11M in Q4 2023. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

  • Fred Alger Management reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
  • Fred Alger Management sold 136,166 HilleVax shares in Q3 2024, an estimated $1.97M.
  • Fred Alger Management first reported a position in HilleVax in Q2 2022 and held it in 9 quarters.
  • Fred Alger Management's HilleVax position peaked at $2.11M in Q4 2023.
  • 79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on Fred Alger Management's 13F filing for Q3 2024, filed 14 Nov 2024.